Brenntag SE
Brenntag SE engages in the distribution of chemicals and ingredients in Germany, the United States, the United Kingdom, China, Canada, Italy, Poland, France, and internationally. It operates in two segments, Brenntag Essentials and Brenntag Specialties. The company provides just-in-time delivery, product mixing, blending, repackaging, inventory management, and drum return handling, as well as app… Read more
Brenntag SE (BNR) - Net Assets
Latest net assets as of September 2025: €4.35 Billion EUR
Based on the latest financial reports, Brenntag SE (BNR) has net assets worth €4.35 Billion EUR as of September 2025.
Net assets (also known as shareholders' equity or book value) represent the difference between a company's total assets (€10.68 Billion) and total liabilities (€6.34 Billion). This figure indicates the residual interest in the assets after deducting liabilities, essentially showing what would remain for shareholders if all assets were liquidated and all debts paid off.
Key Net Assets Metrics
| Metric | Value |
|---|---|
| Current Net Assets | €4.35 Billion |
| % of Total Assets | 40.7% |
| Annual Growth Rate | 7.76% |
| 5-Year Change | 31.85% |
| 10-Year Change | 76.99% |
| Growth Volatility | 7.55 |
Brenntag SE - Net Assets Trend (2013–2024)
This chart illustrates how Brenntag SE's net assets have evolved over time, based on quarterly financial data. Explore and compare other companies by net assets.
Annual Net Assets for Brenntag SE (2013–2024)
The table below shows the annual net assets of Brenntag SE from 2013 to 2024.
| Year | Net Assets | Change |
|---|---|---|
| 2024-12-31 | €4.76 Billion | +9.30% |
| 2023-12-31 | €4.36 Billion | -9.29% |
| 2022-12-31 | €4.80 Billion | +20.21% |
| 2021-12-31 | €4.00 Billion | +10.62% |
| 2020-12-31 | €3.61 Billion | +0.91% |
| 2019-12-31 | €3.58 Billion | +8.42% |
| 2018-12-31 | €3.30 Billion | +10.57% |
| 2017-12-31 | €2.99 Billion | +0.90% |
| 2016-12-31 | €2.96 Billion | +9.99% |
| 2015-12-31 | €2.69 Billion | +14.15% |
| 2014-12-31 | €2.36 Billion | +12.57% |
| 2013-12-31 | €2.09 Billion | -- |
Equity Component Analysis
This analysis shows how different components contribute to Brenntag SE's total equity over time. Equity components include common stock, retained earnings, additional paid-in capital, and other elements.
Equity Composition Insights
- Retained earnings have grown by 585.8% over the analyzed period, indicating profitable operations and earnings retention.
Current Equity Component Breakdown (December 2024)
| Component | Amount | Percentage |
|---|---|---|
| Retained Earnings | €3.68 Billion | 77.77% |
| Other Components | €1.05 Billion | 22.23% |
| Total Equity | €4.73 Billion | 100.00% |
Brenntag SE Competitors by Market Cap
The table below lists competitors of Brenntag SE ranked by their market capitalization.
| Company | Market Cap |
|---|---|
|
OneMain Holdings Inc
NYSE:OMF
|
$5.88 Billion |
|
Aier Eye Hospital Group
SHE:300015
|
$5.88 Billion |
|
Lincoln National Corporation
NYSE:LNC
|
$5.88 Billion |
|
The Hershey Company
SA:HSHY34
|
$5.88 Billion |
|
Paycom Software, Inc.
NYSE:PAYC
|
$5.87 Billion |
|
Meiji Holdings Co. Ltd
F:3M0
|
$5.87 Billion |
|
Zhejiang Satellite Petrochemical Co Ltd
SHE:002648
|
$5.87 Billion |
|
Krystal Biotech Inc
NASDAQ:KRYS
|
$5.87 Billion |
Equity Growth Attribution
This analysis shows how different factors contributed to changes in Brenntag SE's equity between the two most recent reporting periods.
Equity Growth Insights
- From 2023 to 2024, total equity changed from 4,304,700,000 to 4,726,700,000, a change of 422,000,000 (9.8%).
- Net income of 536,200,000 contributed positively to equity growth.
- Dividend payments of 303,200,000 reduced retained earnings.
- Share repurchases of 250,100,000 reduced equity.
- Other factors increased equity by 439,100,000.
Equity Change Factors (2023 to 2024)
| Factor | Impact | Contribution |
|---|---|---|
| Net Income | €536.20 Million | +11.34% |
| Dividends Paid | €303.20 Million | -6.41% |
| Share Repurchases | €250.10 Million | -5.29% |
| Other Changes | €439.10 Million | +9.29% |
| Total Change | €- | 9.80% |
Book Value vs Market Value Analysis
This analysis compares Brenntag SE's book value (net assets) with its market value over time. The relationship between these values can provide insights into investor sentiment and company valuation.
Valuation Insights
- Current price-to-book ratio: 1.52x
- The company is trading above its book value, indicating the market recognizes value beyond its reported assets.
- The price-to-book ratio has decreased from 2.58x to 1.52x over the analyzed period, indicating reduced market premium.
Historical Price-to-Book Ratios
| Date | Book Value per Share | Market Price | P/B Ratio |
|---|---|---|---|
| 2017-12-31 | €19.24 | €49.60 | x |
| 2018-12-31 | €21.21 | €49.60 | x |
| 2019-12-31 | €22.76 | €49.60 | x |
| 2020-12-31 | €22.98 | €49.60 | x |
| 2021-12-31 | €25.33 | €49.60 | x |
| 2022-12-31 | €30.76 | €49.60 | x |
| 2023-12-31 | €29.19 | €49.60 | x |
| 2024-12-31 | €32.74 | €49.60 | x |
Capital Efficiency Dashboard
This dashboard shows how efficiently Brenntag SE utilizes its equity to generate returns, including Return on Equity (ROE) and its components based on the DuPont analysis framework.
Capital Efficiency Insights
- Current Return on Equity (ROE): 11.34%
- The company shows good efficiency in utilizing shareholder equity.
- DuPont Analysis Breakdown:
- • Net Profit Margin: 3.30%
- • Asset Turnover: 1.39x
- • Equity Multiplier: 2.47x
- Recent ROE (11.34%) is below the historical average (13.98%), suggesting potential challenges in capital efficiency.
Historical Capital Efficiency Metrics
| Year | Return on Equity | Net Profit Margin | Asset Turnover | Equity Multiplier | Economic Value Added |
|---|---|---|---|---|---|
| 2013 | 16.42% | 3.47% | 1.74x | 2.72x | €132.64 Million |
| 2014 | 14.59% | 3.39% | 1.61x | 2.67x | €106.75 Million |
| 2015 | 13.79% | 3.53% | 1.48x | 2.64x | €100.36 Million |
| 2016 | 12.22% | 3.43% | 1.44x | 2.47x | €65.35 Million |
| 2017 | 12.14% | 3.07% | 1.61x | 2.45x | €63.48 Million |
| 2018 | 14.07% | 3.67% | 1.63x | 2.35x | €133.25 Million |
| 2019 | 13.27% | 3.64% | 1.50x | 2.44x | €115.12 Million |
| 2020 | 13.14% | 3.96% | 1.45x | 2.29x | €111.53 Million |
| 2021 | 11.45% | 3.12% | 1.41x | 2.60x | €56.88 Million |
| 2022 | 18.66% | 4.56% | 1.71x | 2.39x | €411.55 Million |
| 2023 | 16.61% | 4.25% | 1.63x | 2.40x | €284.43 Million |
| 2024 | 11.34% | 3.30% | 1.39x | 2.47x | €63.53 Million |
Industry Comparison
This section compares Brenntag SE's net assets metrics with peer companies in the Specialty Chemicals industry.
Industry Context
- Industry: Specialty Chemicals
- Average net assets among peers: $20,594,170,595
- Average return on equity (ROE) among peers: -28.41%
Peer Company Comparison
| Company | Net Assets | Return on Equity | Debt-to-Equity | Market Cap |
|---|---|---|---|---|
| Brenntag SE (BNR) | €4.35 Billion | 16.42% | 1.46x | $5.87 Billion |
| Kureha Corporation (0K1) | $162.17 Billion | 8.59% | 0.53x | $845.56 Million |
| Polwax S.A (1LW) | $54.23 Million | -71.97% | 1.06x | $3.33 Million |
| H&R GmbH & Co. KGaA (2HRA) | $287.13 Million | 9.37% | 1.19x | $34.48 Million |
| Renaissance Oil Corp (2R7) | $2.68 Billion | 6.64% | 1.08x | $1.31 Billion |
| Global New Material International Holdings Limited (69Y) | $4.35 Billion | 5.56% | 0.62x | $625.83 Million |
| Altech Chemicals Ltd (A3Y) | $33.88 Million | -176.29% | 0.32x | $18.88 Million |
| Beijing Media Corporation Limited (BME) | $1.20 Billion | -7.10% | 0.16x | $1.77 Million |
| BRAIN Biotech AG (BNN) | $17.59 Million | -23.28% | 0.43x | $40.42 Million |
| Huabao International Holdings Limited (CEY) | $14.56 Billion | -7.24% | 0.14x | $1.44 Billion |